1-Bromo-4-(1,1-difluoroethyl)benzene | CAS:1000994-95-5

We serve 1-Bromo-4-(1,1-difluoroethyl)benzene CAS:1000994-95-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1-Bromo-4-(1,1-difluoroethyl)benzene

Chemical Name:1-Bromo-4-(1,1-difluoroethyl)benzene
CAS.NO:1000994-95-5
Synonyms:1-Bromo-4-(1,1-difluoroethyl)benzene
4-(1,1-Difluoroethyl)phenyl bromide
Molecular Formula:C8H7BrF2
Molecular Weight:221.0419864
 
Physical and Chemical Properties:
Density:1.495
Boiling point:80-82ºC
Flash point:82ºC
Index of Refraction:1.503
 
Specification:
Appearance:Colorless to Yellow clear liquid
Assay(GC):≥98.0%
 
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediates of pharmaceutical



Contact us for information like 1-Bromo-4-(1,1-difluoroethyl)benzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(1,1-Difluoroethyl)phenyl bromide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Bromo-4-(1,1-difluoroethyl)benzene Use and application,1-Bromo-4-(1,1-difluoroethyl)benzene technical grade,usp/ep/jp grade.


Related News: Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs.(4-Butoxy-2,3-difluorophenyl)boronic acid manufacturer Airlines operating in the United States will be required to ask all passengers booked on flights from outside the US if they’ve been to mainland China in last 14 days.(S)-(+)-GLYCIDYL PHTHALIMIDE supplier Airlines operating in the United States will be required to ask all passengers booked on flights from outside the US if they’ve been to mainland China in last 14 days.4-METHYL-2-NITROPHENYL ISOTHIOCYANATE vendor At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.